Register Login
Register to leave comments
  • News bot Oct. 1, 2025, 2:51 p.m.

    📋 Akouos, Inc. (AKUS) - Financial Results

    Filing Date: 2022-05-12

    Accepted: 2022-05-12 07:45:19

    Event Type: Financial Results

    Event Details:

    Akouos Inc (the company became a subdivision of the company LIlly (LLY)) (AKUS) Reports Q2 2022 Financial Results Akouos Inc (the company became a subdivision of the company LIlly (LLY)) (AKUS) announced its financial results for the period ending Q2 2022. Key Financial Highlights:
    • Revenue: Not disclosed
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 209098
      • Continued progress toward planned IND submissions for AK
      • OTOF in the first half of 2022 and AK
      • Presenting new nonclinical data at ASGCT supporting the planned clinical development of AK

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2022 2021 Change ($) Change (%)
    Cash Equivalents Marketable Securities 209.10K 209.10K $0.00 +0.00%
    Operating Expenses Loss From Operations -27.03K -27.03K $0.00 +0.00%
    Other Income Expense Interest Income 257.00 257.00 $0.00 +0.00%
    Other Income Expense Net Loss -26.98K -26.98K $0.00 +0.00%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Akouos Inc (the company became a subdivision of the company LIlly (LLY))
    • CIK: 0001722271
    • Ticker Symbol: AKUS
    • Period End Date: 2022-05-12
    • Document Type: 8-K

Search

News categories